What it sells
Cuts pharma validation timelines from months to weeks
Business model breakdown
Buyer: who owns the budget?
UnverifiedHead of Quality/Validation or QA/IT compliance at pharma companies.
Trigger: what makes them buy now?
Validation takes months and documentation goes obsolete as systems change; pressure for AI-era compliance.
Workflow: what inputs become what output?
Replaces static document-based computer system validation with a modular platform: change, deviation, test, incident, periodic-review and supplier management, digital repository with e-sign, AI-assisted validation.
Economics: what it saves and how it charges
UnverifiedSaaS licence per modular platform (pricing not shown).
Distribution: how it reaches customers
Demo-led sales ('Get a Demo'), events and content marketing.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| 2026-04-01 | Pre-seed | $1.2M | — | news.google.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.